education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Irbosyd
Irbosyd
mebeverine
Manufacturer:
Fahrenheit
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Mebeverine HCl
Indications/Uses
Irritable bowel syndrome.
Dosage/Direction for Use
1 tab 3 times daily.
Administration
May be taken with or without food: Preferably taken 20 min before or w/ meals.
Special Precautions
Cardiac disorders. Hepatic dysfunction, advanced renal disease. Pregnancy & lactation. Childn <10 yr.
Adverse Reactions
Indigestion, heartburn, dizziness, insomnia, anorexia, headache, bradycardia, constipation, general malaise.
View
ADR Monitoring Form
MIMS Class
Antispasmodics
ATC Classification
A03AA04 - mebeverine ; Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
Regulatory Classification
G
Presentation/Packing
Form
Irbosyd film-coated tab 135 mg
Packing/Price
30's (Rp75,000/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in